-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cero Therapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q3 2024.
- Cero Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.4M, a 187% decline year-over-year.
- Cero Therapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$14.1M.
- Cero Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$2.93M, a 0.95% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)